Pharma Journalist -

Now in its 17th year, E&L Europe is set to take place on 6-7 November in Amsterdam and once again will feature leading industry experts covering the most pertinent topics impacting…
Read More...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) for the prevention of RSV…
Read More...

Valneva SE, a specialty vaccine company, today announced the signing of a new $32 million contract with the United States (U.S.) Department of Defense (DoD) for the supply of its…
Read More...

Jazz Pharmaceuticals plc announced that the European Commission (EC) has granted marketing authorization for Enrylaze (JZP458; a recombinant Erwinia asparaginase or crisantaspase) for…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR),…
Read More...

JURA Bio, a biotechnology company developing immune-based therapeutics using machine learning and synthetic biology, announced a research collaboration with Syena, a cell therapy…
Read More...

Debiopharm, a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, announced an exclusive…
Read More...

Merck, known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a supplemental new drug…
Read More...

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company announced a new multi-target collaboration and license agreement with U.S.-based Genentech, a member of the…
Read More...

BeiGene, Ltd. announced that it has entered into an agreement with Novartis to regain worldwide rights to develop, manufacture, and commercialize TEVIMBRA (tislelizumab). “We are…
Read More...